Triple-negative breast cancer: Heterogeneity, tumor microenvironment and targeted therapy

被引：4
|
作者：
Deng, Xiyun [1 ]
Zheng, Chanjuan [1 ]
Tang, Faqing [2 ,3 ]
Rosol, Thomas J. J. [4 ]
Shao, Zhi-Ming [5 ,6 ]
机构：
[1] Hunan Normal Univ, Key Lab Translat Canc Stem Cell Res, Sch Med, Changsha, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Sch Med, Hunan Key Lab Oncotarget Gene, Clin Lab,Hunan Canc Hosp, Changsha, Hunan, Peoples R China
[3] Cent South Univ, Affiliated Canc Hosp, Hunan Key Lab Oncotarget Gene, Xiangya Sch Med, Changsha, Hunan, Peoples R China
[4] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH USA
[5] Fudan Univ, Shanghai Med Coll, Shanghai Canc Ctr, Key Lab Breast Canc Shanghai,Dept Breast Surg, Shanghai, Peoples R China
[6] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
来源：
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
基金：
中国国家自然科学基金;
关键词：
triple-negative breast cancer; heterogeneity; tumor microenvironment; targeted therapy; clinical outcomes;
D O I：
10.3389/fonc.2022.1026566
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Targeted Therapies for Triple-Negative Breast Cancer
    Tomas G. Lyons
    Current Treatment Options in Oncology, 2019, 20
  • [22] Epigenetic modulations in triple-negative breast cancer: Therapeutic implications for tumor microenvironment
    Zhou, Linlin
    Yu, Chen -Wei
    PHARMACOLOGICAL RESEARCH, 2024, 204
  • [23] Targeted Therapies for Triple-Negative Breast Cancer
    Lyons, Tomas G.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (11)
  • [24] Targeted Drug Therapy to Overcome Chemoresistance in Triple-negative Breast Cancer
    Kumari, Mamta
    Krishnamurthy, Praveen Thaggikuppe
    Sola, Piyong
    CURRENT CANCER DRUG TARGETS, 2020, 20 (08) : 559 - 572
  • [25] Current Issues of Targeted Therapy in Metastatic Triple-Negative Breast Cancer
    Liedtke, Cornelia
    Kiesel, Ludwig
    BREAST CARE, 2011, 6 (03) : 234 - 239
  • [26] Targeting therapy and tumor microenvironment remodeling of triple-negative breast cancer by ginsenoside Rg3 based liposomes
    Jiaxuan Xia
    Shuya Zhang
    Ru Zhang
    Anni Wang
    Ying Zhu
    Meichen Dong
    Shaojie Ma
    Chao Hong
    Shengyao Liu
    Dan Wang
    Jianxin Wang
    Journal of Nanobiotechnology, 20
  • [27] Targeting therapy and tumor microenvironment remodeling of triple-negative breast cancer by ginsenoside Rg3 based liposomes
    Xia, Jiaxuan
    Zhang, Shuya
    Zhang, Ru
    Wang, Anni
    Zhu, Ying
    Dong, Meichen
    Ma, Shaojie
    Hong, Chao
    Liu, Shengyao
    Wang, Dan
    Wang, Jianxin
    JOURNAL OF NANOBIOTECHNOLOGY, 2022, 20 (01)
  • [28] Enhanced Thermogenesis in Triple-Negative Breast Cancer Is Associated with Pro-Tumor Immune Microenvironment
    Gandhi, Shipra
    Oshi, Masanori
    Murthy, Vijayashree
    Repasky, Elizabeth A.
    Takabe, Kazuaki
    CANCERS, 2021, 13 (11)
  • [29] Recent progress in small molecule agents for the targeted therapy of triple-negative breast cancer
    Islam, Rajibul
    Lam, Kok Wai
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 207
  • [30] Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
    Camorani, Simona
    Passariello, Margherita
    Agnello, Lisa
    Esposito, Silvia
    Collina, Francesca
    Cantile, Monica
    Di Bonito, Maurizio
    Ulasov, Ilya V.
    Fedele, Monica
    Zannetti, Antonella
    De Lorenzo, Claudia
    Cerchia, Laura
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)
12345